66
can Brain Imaging Tell can Brain Imaging Tell Us? Us? Thomas E. Freese, Ph.D Thomas E. Freese, Ph.D Director Director Pacific Southwest Addiction Technology Transfer Pacific Southwest Addiction Technology Transfer Center Center Asst. Research Psychologist Asst. Research Psychologist Semel Institute for Neuroscience and Human Behavior Semel Institute for Neuroscience and Human Behavior David Geffen School of Medicine David Geffen School of Medicine University of California at Los Angeles University of California at Los Angeles www.psattc.org www.psattc.org www.uclaisap.org www.uclaisap.org [email protected] [email protected] Supported by: Supported by: Supported by: Supported by: National Institute on Drug Abuse (NIDA) National Institute on Drug Abuse (NIDA) Pacific Southwest Technology Transfer Center (SAMHSA) Pacific Southwest Technology Transfer Center (SAMHSA) International Network of Treatment and Rehabilitation Resource Centres International Network of Treatment and Rehabilitation Resource Centres (UNODC) (UNODC) May 24, 2006 Orlanndo, Florida

Methamphetamine: What can Brain Imaging Tell Us? Thomas E. Freese, Ph.D Director Pacific Southwest Addiction Technology Transfer Center Asst. Research

Embed Size (px)

Citation preview

Page 1: Methamphetamine: What can Brain Imaging Tell Us? Thomas E. Freese, Ph.D Director Pacific Southwest Addiction Technology Transfer Center Asst. Research

Methamphetamine: What Methamphetamine: What can Brain Imaging Tell Us?can Brain Imaging Tell Us?

Thomas E. Freese, Ph.DThomas E. Freese, Ph.D

DirectorDirectorPacific Southwest Addiction Technology Transfer Pacific Southwest Addiction Technology Transfer CenterCenter

Asst. Research PsychologistAsst. Research PsychologistSemel Institute for Neuroscience and Human BehaviorSemel Institute for Neuroscience and Human BehaviorDavid Geffen School of MedicineDavid Geffen School of MedicineUniversity of California at Los AngelesUniversity of California at Los Angeles

www.psattc.orgwww.psattc.orgwww.uclaisap.orgwww.uclaisap.orgtefreese@[email protected]

Supported by:Supported by: Supported by:Supported by: National Institute on Drug Abuse (NIDA)National Institute on Drug Abuse (NIDA) Pacific Southwest Technology Transfer Center (SAMHSA)Pacific Southwest Technology Transfer Center (SAMHSA) International Network of Treatment and Rehabilitation Resource Centres International Network of Treatment and Rehabilitation Resource Centres (UNODC)(UNODC)

May 24, 2006 Orlanndo, Florida

Page 2: Methamphetamine: What can Brain Imaging Tell Us? Thomas E. Freese, Ph.D Director Pacific Southwest Addiction Technology Transfer Center Asst. Research

MethamphetamineMethamphetamine

Methamphetamine is a powerful Methamphetamine is a powerful central nervous system stimulantcentral nervous system stimulant that strongly activates multiple that strongly activates multiple systems in the brain. systems in the brain. Methamphetamine is closely Methamphetamine is closely related chemically to related chemically to amphetamine, but the central amphetamine, but the central nervous system effects of nervous system effects of methamphetamine are greater. methamphetamine are greater.

Page 3: Methamphetamine: What can Brain Imaging Tell Us? Thomas E. Freese, Ph.D Director Pacific Southwest Addiction Technology Transfer Center Asst. Research

Forms of Forms of MethamphetamineMethamphetamineMethamphetamine Powder

Description: Beige/yellowy/off-white powder

Base / Paste MethamphetamineDescription: ‘Oily’, ‘gunky’, ‘gluggy’ gel, moist, waxy

Crystalline Methamphetamine

IDU Description: White/clear crystals/rocks; ‘crushed glass’ / ‘rock salt’

Page 4: Methamphetamine: What can Brain Imaging Tell Us? Thomas E. Freese, Ph.D Director Pacific Southwest Addiction Technology Transfer Center Asst. Research

EPHEDRINE

OH

CC

HHH

3CH 3CH

N

METHAMPHETAM INE

H

CC

HHH

3CH 3CH

N

Page 5: Methamphetamine: What can Brain Imaging Tell Us? Thomas E. Freese, Ph.D Director Pacific Southwest Addiction Technology Transfer Center Asst. Research

The Methamphetamine The Methamphetamine Epidemic:Epidemic:Admissions/100,000: 1992-Admissions/100,000: 1992-20032003

0

50

100

150

200

250

300

350

1992

1993

1994

1995

1996

1997

1998

1999

2000

2001

2002

2003

California

Hawaii

I owa

Oregon

Washington

It keeps going up

Page 6: Methamphetamine: What can Brain Imaging Tell Us? Thomas E. Freese, Ph.D Director Pacific Southwest Addiction Technology Transfer Center Asst. Research

Methamphetamine/Amphetamine Treatment Admissions, by Route of

Administration: 1992-2002

Source: 2002 SAMHSA Treatment Episode Data Set (TEDS).

Page 7: Methamphetamine: What can Brain Imaging Tell Us? Thomas E. Freese, Ph.D Director Pacific Southwest Addiction Technology Transfer Center Asst. Research
Page 8: Methamphetamine: What can Brain Imaging Tell Us? Thomas E. Freese, Ph.D Director Pacific Southwest Addiction Technology Transfer Center Asst. Research

People use drugs for two reasons:

1) To feel good.

2) To feel better

People use drugs for two reasons:

1) To feel good.

2) To feel better

Page 9: Methamphetamine: What can Brain Imaging Tell Us? Thomas E. Freese, Ph.D Director Pacific Southwest Addiction Technology Transfer Center Asst. Research

In other words:

A Major Reason People Take a Drug is they Like

What It Does to Their Brains

In other words:

A Major Reason People Take a Drug is they Like

What It Does to Their Brains

Page 10: Methamphetamine: What can Brain Imaging Tell Us? Thomas E. Freese, Ph.D Director Pacific Southwest Addiction Technology Transfer Center Asst. Research

00

5050

100100

150150

200200

00 6060 120120 180180

Time (min)Time (min)

% o

f B

asal

DA

Ou

tpu

t%

of

Bas

al D

A O

utp

ut

NAc shellNAc shell

EmptyEmpty

BoxBox FeedingFeeding

Source: Di Chiara et al.Source: Di Chiara et al.

FOODFOOD

100100

150150

200200

DA

Co

nce

ntr

ati

on

(%

Bas

elin

e)D

A C

on

cen

tra

tio

n (

% B

asel

ine)

MountsMountsIntromissionsIntromissionsEjaculationsEjaculations

1515

00

55

1010

Co

pu

latio

n F

req

ue

nc

yC

op

ula

tion

Fre

qu

en

cy

SampleNumberSampleNumber

11 22 33 44 55 66 77 88 99 1010 1111 1212 1313 1414 1515 1616 1717

ScrScrScrScrBasBasFemale 1 PresentFemale 1 Present

ScrScrFemale 2 PresentFemale 2 Present

ScrScr

Source: Fiorino and PhillipsSource: Fiorino and Phillips

SEXSEX

Natural Rewards Elevate Natural Rewards Elevate Dopamine LevelsDopamine Levels

Natural Rewards Elevate Natural Rewards Elevate Dopamine LevelsDopamine Levels

Page 11: Methamphetamine: What can Brain Imaging Tell Us? Thomas E. Freese, Ph.D Director Pacific Southwest Addiction Technology Transfer Center Asst. Research

Source: Shoblock and Sullivan; Di Chiara and Imperato

Effects of Drugs on Dopamine Effects of Drugs on Dopamine ReleaseRelease

00

100100

200200

300300

400400

Time After CocaineTime After Cocaine

% o

f B

as

al

Re

lea

se

% o

f B

as

al

Re

lea

se

DADADOPACDOPACHVAHVA

AccumbensAccumbens COCAINECOCAINE

100

150

200

250

0 1 2 3 4hrTime After Ethanol

% o

f B

as

al

Re

lea

se

0.250.512.5

Accumbens

0

Dose (g/kg ip)

ETHANOL

00

100100

150150

200200

250250

00 11 22 3 hr3 hr

Time After NicotineTime After Nicotine

% o

f B

as

al

Re

lea

se

% o

f B

as

al

Re

lea

se

AccumbensAccumbensCaudateCaudate

NICOTINENICOTINE

Time After Methamphetamine

% B

as

al

Re

lea

se

METHAMPHETAMINE

0 1 2 3hr

1500

1000

500

0

Accumbens

Page 12: Methamphetamine: What can Brain Imaging Tell Us? Thomas E. Freese, Ph.D Director Pacific Southwest Addiction Technology Transfer Center Asst. Research

What Can Imaging Tell What Can Imaging Tell Us?Us?

In design of In design of new medications new medications – knowledge – knowledge of affected circuitry can point to of affected circuitry can point to chemical chemical dysfunction dysfunction that may be helped by that may be helped by medication.medication.

In the design of In the design of behavioral treatments behavioral treatments it it can tell you the can tell you the types and severity of types and severity of deficits deficits and dysfunctions in the brain and and dysfunctions in the brain and the the timetable of their recovery timetable of their recovery (or not). (or not). This information can be helpful in guiding This information can be helpful in guiding the behavioral targets for treatment and the behavioral targets for treatment and the types and durations of treatment that the types and durations of treatment that can best accommodate the brain recovery can best accommodate the brain recovery

Brain imaging can show Brain imaging can show how much viable how much viable tissue tissue there is to work with. And, it can there is to work with. And, it can show the show the affect of treatmentaffect of treatment..

Page 13: Methamphetamine: What can Brain Imaging Tell Us? Thomas E. Freese, Ph.D Director Pacific Southwest Addiction Technology Transfer Center Asst. Research

Imaging ModalitiesImaging Modalities

Regional FunctionRegional Function Specific Specific NeurochemistryNeurochemistry

PETPET MetabolismMetabolism

Blood FlowBlood FlowNeurotransmitterNeurotransmitters & their s & their ReceptorsReceptors

SPECTSPECT Blood Flow “poor-Blood Flow “poor-mans PET”mans PET”

NeurotransmitterNeurotransmitters & their s & their ReceptorsReceptors

MRIMRI Correlates of Correlates of Blood FlowBlood Flow

1.1. SpectroscopySpectroscopy

2.2. Diffusion Diffusion Tensor Tensor ImagingImaging

Page 14: Methamphetamine: What can Brain Imaging Tell Us? Thomas E. Freese, Ph.D Director Pacific Southwest Addiction Technology Transfer Center Asst. Research

Brain Function in Brain Function in Methamphetamine Methamphetamine AbusersAbusers Do METH abusers show Do METH abusers show

abnormalities in brain abnormalities in brain metabolitesmetabolites??

Do brain metabolite abnormalities Do brain metabolite abnormalities relate to cognitive performancerelate to cognitive performance – – such as selective attention?such as selective attention?

Does the brain Does the brain recover following recover following cessationcessation of METH use? of METH use?

Page 15: Methamphetamine: What can Brain Imaging Tell Us? Thomas E. Freese, Ph.D Director Pacific Southwest Addiction Technology Transfer Center Asst. Research

Prolonged Drug Use ChangesProlonged Drug Use Changesthe Brain In Fundamentalthe Brain In Fundamentaland Long-Lasting Waysand Long-Lasting Ways

Page 16: Methamphetamine: What can Brain Imaging Tell Us? Thomas E. Freese, Ph.D Director Pacific Southwest Addiction Technology Transfer Center Asst. Research

Source: McCann U.D.. et al.,Journal of Neuroscience, 18, pp. 8417-8422, October 15, 1998.

Decreased dopamine Decreased dopamine transporter binding in METH transporter binding in METH users resembles that in users resembles that in Parkinson’s Disease Parkinson’s Disease

Control Meth PD

Page 17: Methamphetamine: What can Brain Imaging Tell Us? Thomas E. Freese, Ph.D Director Pacific Southwest Addiction Technology Transfer Center Asst. Research

Partial Recovery of Brain Dopamine Transporters in

MethamphetamineAbuser After Protracted

Abstinence

Normal Control METH Abuser(1 month detox)

METH Abuser(24 months detox)

0

3

ml/gm

Source: Volkow, ND et al., Journal of Neuroscience 21, 9414-9418, 2001.

Page 18: Methamphetamine: What can Brain Imaging Tell Us? Thomas E. Freese, Ph.D Director Pacific Southwest Addiction Technology Transfer Center Asst. Research
Page 19: Methamphetamine: What can Brain Imaging Tell Us? Thomas E. Freese, Ph.D Director Pacific Southwest Addiction Technology Transfer Center Asst. Research
Page 20: Methamphetamine: What can Brain Imaging Tell Us? Thomas E. Freese, Ph.D Director Pacific Southwest Addiction Technology Transfer Center Asst. Research
Page 21: Methamphetamine: What can Brain Imaging Tell Us? Thomas E. Freese, Ph.D Director Pacific Southwest Addiction Technology Transfer Center Asst. Research
Page 22: Methamphetamine: What can Brain Imaging Tell Us? Thomas E. Freese, Ph.D Director Pacific Southwest Addiction Technology Transfer Center Asst. Research

Meth

Page 23: Methamphetamine: What can Brain Imaging Tell Us? Thomas E. Freese, Ph.D Director Pacific Southwest Addiction Technology Transfer Center Asst. Research

Meth

Page 24: Methamphetamine: What can Brain Imaging Tell Us? Thomas E. Freese, Ph.D Director Pacific Southwest Addiction Technology Transfer Center Asst. Research

Meth

Page 25: Methamphetamine: What can Brain Imaging Tell Us? Thomas E. Freese, Ph.D Director Pacific Southwest Addiction Technology Transfer Center Asst. Research

Meth

Page 26: Methamphetamine: What can Brain Imaging Tell Us? Thomas E. Freese, Ph.D Director Pacific Southwest Addiction Technology Transfer Center Asst. Research

Their Brains

have been

Re-Wired by Drug Use

Their Brains

have been

Re-Wired by Drug Use

Because…Because…

Page 27: Methamphetamine: What can Brain Imaging Tell Us? Thomas E. Freese, Ph.D Director Pacific Southwest Addiction Technology Transfer Center Asst. Research

Some Recent FindingsSome Recent Findings

Methamphetamine abusers have Methamphetamine abusers have deficits in:deficits in:

prefrontal cortex prefrontal cortex ((working working memorymemory) Edythe London et al) Edythe London et al

anterior cingulate gyrus anterior cingulate gyrus ((selective selective attentionattention) Nordahl, Salo et al, Salo, ) Nordahl, Salo et al, Salo, Nordahl et al, Taylor et alNordahl et al, Taylor et al

temporal lobe temporal lobe ((episodic memory, episodic memory, depression)depression) London et al London et al

Page 28: Methamphetamine: What can Brain Imaging Tell Us? Thomas E. Freese, Ph.D Director Pacific Southwest Addiction Technology Transfer Center Asst. Research

SpeculationSpeculation

Cognitive deficits in Cognitive deficits in methamphetamine abusers are methamphetamine abusers are likely to reflect damage in likely to reflect damage in anterior brain regions, such as anterior brain regions, such as anterior cingulum, that anterior cingulum, that could could contribute tocontribute to their clinical their clinical presentation of presentation of inattention and inattention and distractibilitydistractibility. .

Page 29: Methamphetamine: What can Brain Imaging Tell Us? Thomas E. Freese, Ph.D Director Pacific Southwest Addiction Technology Transfer Center Asst. Research

Control > MA

4

3

2

0

1

Page 30: Methamphetamine: What can Brain Imaging Tell Us? Thomas E. Freese, Ph.D Director Pacific Southwest Addiction Technology Transfer Center Asst. Research

MA > Control

5

4

2

0

1

3

Page 31: Methamphetamine: What can Brain Imaging Tell Us? Thomas E. Freese, Ph.D Director Pacific Southwest Addiction Technology Transfer Center Asst. Research

Cognitive and Cognitive and

Memory EffectsMemory Effects

Page 32: Methamphetamine: What can Brain Imaging Tell Us? Thomas E. Freese, Ph.D Director Pacific Southwest Addiction Technology Transfer Center Asst. Research

Differences between Stimulant and Differences between Stimulant and Comparison Groups on tests Comparison Groups on tests requiring perceptual speedrequiring perceptual speed

0

20

40

60

80

100

Mea

n S

core

s

Digit Symbol** Trail Making A* Trail Making B**

Stimulant (n=80) Comparison (n=80

Page 33: Methamphetamine: What can Brain Imaging Tell Us? Thomas E. Freese, Ph.D Director Pacific Southwest Addiction Technology Transfer Center Asst. Research

Memory Difference between Memory Difference between Stimulant and Comparison Stimulant and Comparison GroupsGroups

0

1

2

3

4

5

6

7

Mea

n S

core

s

Word Recall** Picture Recall**

Comparison (n=80) Meth (n=80)

Page 34: Methamphetamine: What can Brain Imaging Tell Us? Thomas E. Freese, Ph.D Director Pacific Southwest Addiction Technology Transfer Center Asst. Research

Longitudinal Memory Longitudinal Memory PerformancePerformance

test

num

ber

corr

ect

0

5

10

15

20

25

Word Recall WordRecognition

Picture Recall PictureRecognition

controlbaseline3 mos6 mos

Page 35: Methamphetamine: What can Brain Imaging Tell Us? Thomas E. Freese, Ph.D Director Pacific Southwest Addiction Technology Transfer Center Asst. Research

% I

mpair

ed

0

10

20

30

40

50

60

0

10

20

30

40

50

60ControlsMA Users

Learningand

Memory

Frequency of Impairment by Neuropsychological Domain

Attention/Psychomotor

Speed

WorkingMemory

Fluency Inhibition

Executive Systems Function

Page 36: Methamphetamine: What can Brain Imaging Tell Us? Thomas E. Freese, Ph.D Director Pacific Southwest Addiction Technology Transfer Center Asst. Research

Defining Domains:Defining Domains: Executive Systems Executive Systems FunctioningFunctioning a.k.a. frontal lobe functioning.a.k.a. frontal lobe functioning. Deficits on executive tasks assoc. Deficits on executive tasks assoc.

w/:w/:– Poor judgment.Poor judgment.– Lack of insight.Lack of insight.– Poor strategy formation.Poor strategy formation.– Impulsivity.Impulsivity.– Reduced capacity to determine Reduced capacity to determine

consequences of actions.consequences of actions.

Page 37: Methamphetamine: What can Brain Imaging Tell Us? Thomas E. Freese, Ph.D Director Pacific Southwest Addiction Technology Transfer Center Asst. Research

Brain Serotonin Transporter Brain Serotonin Transporter Density and Aggression in Density and Aggression in Abstinent Methamphetamine Abstinent Methamphetamine AbusersAbusers

Sekine, Y, Ouchi, Y, Takei, N, et al. Brain Serotonin Transporter Sekine, Y, Ouchi, Y, Takei, N, et al. Brain Serotonin Transporter Density and Aggression in Abstinent Methamphetamine Density and Aggression in Abstinent Methamphetamine Abusers. Abusers. Arch Gen Psychiatry.Arch Gen Psychiatry. 2006;63:90-100. 2006;63:90-100.

Page 38: Methamphetamine: What can Brain Imaging Tell Us? Thomas E. Freese, Ph.D Director Pacific Southwest Addiction Technology Transfer Center Asst. Research

Objective of StudyObjective of Study

Investigate the status of brain Investigate the status of brain serotonin neurons and their serotonin neurons and their possible relationship with clinical possible relationship with clinical characteristics in currently characteristics in currently abstinent methamphetamine abstinent methamphetamine abusers.abusers.

Page 39: Methamphetamine: What can Brain Imaging Tell Us? Thomas E. Freese, Ph.D Director Pacific Southwest Addiction Technology Transfer Center Asst. Research

ResultsResults 1.1. Serotonin transporter density in global brain Serotonin transporter density in global brain

regions was significantly lower in regions was significantly lower in methamphetamine abusersmethamphetamine abusers

• Suggests that abuse of methamphetamine Suggests that abuse of methamphetamine leads to a leads to a global and severe reductionglobal and severe reduction in in the density of human brain the density of human brain serotonin serotonin transporterstransporters

2.2. Values of serotonin transporter density in Values of serotonin transporter density in widely distributed brain regions were found widely distributed brain regions were found to negatively correlate with the duration of to negatively correlate with the duration of methamphetamine use.methamphetamine use.

• Suggests that Suggests that the longerthe longer methamphetamine is used, methamphetamine is used, the more the more severesevere the decrease in serotonin the decrease in serotonin transporter density.transporter density.

Page 40: Methamphetamine: What can Brain Imaging Tell Us? Thomas E. Freese, Ph.D Director Pacific Southwest Addiction Technology Transfer Center Asst. Research

Results (Continued)Results (Continued)3.3. Magnitude of aggression Magnitude of aggression in methamphetamine abusers in methamphetamine abusers

increased significantly increased significantly with decreasing serotonin with decreasing serotonin transporter densitiestransporter densities in some brain regions. in some brain regions.

• Bitofrontal cortex, anterior cingulate, temporal cortexBitofrontal cortex, anterior cingulate, temporal cortex

4.4. No correlationNo correlation between a representative measure of between a representative measure of serotonin transporter density and the serotonin transporter density and the duration of duration of methamphetamine abstinencemethamphetamine abstinence. Individuals abstinent . Individuals abstinent for > 1 year still had a substantial decrease in for > 1 year still had a substantial decrease in serotonin transporter density.serotonin transporter density.

• Suggests reductions in the density of the serotonin Suggests reductions in the density of the serotonin transporter in the brain transporter in the brain could persist long after could persist long after methamphetamine use ceasesmethamphetamine use ceases..

Page 41: Methamphetamine: What can Brain Imaging Tell Us? Thomas E. Freese, Ph.D Director Pacific Southwest Addiction Technology Transfer Center Asst. Research

Methamphetamine Use, Self-Reported Methamphetamine Use, Self-Reported Violent Crime, and Recidivism Among Violent Crime, and Recidivism Among Offenders in California Who Abuse Offenders in California Who Abuse Substances Substances

Cartier J, Farabee D, Prendergast M. Methamphetamine Use, Cartier J, Farabee D, Prendergast M. Methamphetamine Use, Self-Reported Violent Crime, and Recidivism Among Offenders Self-Reported Violent Crime, and Recidivism Among Offenders in California Who Abuse Substances. in California Who Abuse Substances. Journal of Interpersonal Journal of Interpersonal Violence.Violence. 2006;21:435-445. 2006;21:435-445.

Page 42: Methamphetamine: What can Brain Imaging Tell Us? Thomas E. Freese, Ph.D Director Pacific Southwest Addiction Technology Transfer Center Asst. Research

Objective of StudyObjective of Study

Examine the associations Examine the associations between methamphetamine (MA) between methamphetamine (MA) use and three measures of use and three measures of criminal behavior: (a) self-criminal behavior: (a) self-reported violent criminal reported violent criminal behavior, (b) return to prison for a behavior, (b) return to prison for a violent offense, and (c) return to violent offense, and (c) return to prison for any reason.prison for any reason.

Page 43: Methamphetamine: What can Brain Imaging Tell Us? Thomas E. Freese, Ph.D Director Pacific Southwest Addiction Technology Transfer Center Asst. Research

MethodsMethods ParticipantsParticipants

– 808 low- to medium-level inmates808 low- to medium-level inmates Clear history of substance abuseClear history of substance abuse Within 12 months of releaseWithin 12 months of release Half the sample entering an in-prison Half the sample entering an in-prison

substance abuse (SA) program and the substance abuse (SA) program and the other half from a neighboring prison other half from a neighboring prison that offered no formal SA treatmentthat offered no formal SA treatment

Matched by age, ethnicity, sex Matched by age, ethnicity, sex offender status, and commitment offender status, and commitment offenseoffense

Page 44: Methamphetamine: What can Brain Imaging Tell Us? Thomas E. Freese, Ph.D Director Pacific Southwest Addiction Technology Transfer Center Asst. Research

Methods ContinuedMethods Continued

• Baseline and 12-Month Follow-Up Baseline and 12-Month Follow-Up InterviewsInterviews Modified versions of criminal justice Modified versions of criminal justice

treatment evaluation forms developed by treatment evaluation forms developed by researchers at Texas Christian Universityresearchers at Texas Christian University

Sections on sociodemographic Sections on sociodemographic background, family and peer relations, background, family and peer relations, health and psychological status, criminal health and psychological status, criminal involvement, in-depth drug-use history, involvement, in-depth drug-use history, and an AIDS-risk assessmentand an AIDS-risk assessment

Page 45: Methamphetamine: What can Brain Imaging Tell Us? Thomas E. Freese, Ph.D Director Pacific Southwest Addiction Technology Transfer Center Asst. Research

ResultsResults

Those who used MA (81.6%) were Those who used MA (81.6%) were significantly more likely than significantly more likely than those who did not use MA (53.9%) those who did not use MA (53.9%) to have been to have been returned to custodyreturned to custody for any reason or to for any reason or to report report committing any violent actscommitting any violent acts in the in the 30 days prior to follow-up (23.6% 30 days prior to follow-up (23.6% vs. 6.8%, respectively)vs. 6.8%, respectively)

Page 46: Methamphetamine: What can Brain Imaging Tell Us? Thomas E. Freese, Ph.D Director Pacific Southwest Addiction Technology Transfer Center Asst. Research

Results ContinuedResults Continued

After controlling for drug trade After controlling for drug trade involvement, MA use was still involvement, MA use was still significantly significantly predictive of self-predictive of self-reported violent crimereported violent crime and and general recidivismgeneral recidivism

Page 47: Methamphetamine: What can Brain Imaging Tell Us? Thomas E. Freese, Ph.D Director Pacific Southwest Addiction Technology Transfer Center Asst. Research

Implications of ResultsImplications of Results

• These findings suggest that These findings suggest that offenders who use MA may differ offenders who use MA may differ significantly from their peers who do significantly from their peers who do not use MA and may require not use MA and may require more more intensive treatment interventionsintensive treatment interventions and and parole supervisionparole supervision than other than other types of offenders who use drugstypes of offenders who use drugs

Page 48: Methamphetamine: What can Brain Imaging Tell Us? Thomas E. Freese, Ph.D Director Pacific Southwest Addiction Technology Transfer Center Asst. Research

Neural Activation Patterns of Neural Activation Patterns of Methamphetamine-Methamphetamine-Dependent Subjects During Dependent Subjects During Decision Making Predict Decision Making Predict Relapse Relapse

Paulus M, Tapert S, Schuckit M. Neural Activation Paulus M, Tapert S, Schuckit M. Neural Activation Patterns of Methamphetamine-Dependent Subjects Patterns of Methamphetamine-Dependent Subjects During Decision Making Predict Relapse. During Decision Making Predict Relapse. Arch Gen Arch Gen Psychiatry.Psychiatry. 2005;62:761-768. 2005;62:761-768.

Page 49: Methamphetamine: What can Brain Imaging Tell Us? Thomas E. Freese, Ph.D Director Pacific Southwest Addiction Technology Transfer Center Asst. Research

Objective of StudyObjective of Study

To determine whether functional To determine whether functional magnetic resonance imaging magnetic resonance imaging (fMRI) during a decision-making (fMRI) during a decision-making task can be used to predict task can be used to predict relapse in treatment-seeking relapse in treatment-seeking methamphetamine-dependent methamphetamine-dependent individuals individuals

Page 50: Methamphetamine: What can Brain Imaging Tell Us? Thomas E. Freese, Ph.D Director Pacific Southwest Addiction Technology Transfer Center Asst. Research

MethodsMethods ParticipantsParticipants

– 46 treatment-seeking males46 treatment-seeking males Met criteria for current dependence on Met criteria for current dependence on

methamphetamine (MA)methamphetamine (MA) Not dependent on any other drug or on Not dependent on any other drug or on

alcoholalcohol Voluntarily entered and completed a 28-Voluntarily entered and completed a 28-

day inpatient programday inpatient program At the time of scanning, abstinent from MAAt the time of scanning, abstinent from MA

Page 51: Methamphetamine: What can Brain Imaging Tell Us? Thomas E. Freese, Ph.D Director Pacific Southwest Addiction Technology Transfer Center Asst. Research

Methods ContinuedMethods Continued• Interview-based symptomatic Interview-based symptomatic

assessmentassessment• fMRI tasksfMRI tasks

2-choice prediction task2-choice prediction task Response taskResponse task

• Outcome measureOutcome measure Blood oxygen level-dependent fMRI Blood oxygen level-dependent fMRI

activation during tasksactivation during tasks

Page 52: Methamphetamine: What can Brain Imaging Tell Us? Thomas E. Freese, Ph.D Director Pacific Southwest Addiction Technology Transfer Center Asst. Research

Methods ContinuedMethods Continued Follow-UpFollow-Up

– Contacted 1 year after imaging Contacted 1 year after imaging sessionsession

– Sobriety assessed using a Sobriety assessed using a questionnairequestionnaire

– Relapse defined as any use of MA Relapse defined as any use of MA during any time after dischargeduring any time after discharge

Page 53: Methamphetamine: What can Brain Imaging Tell Us? Thomas E. Freese, Ph.D Director Pacific Southwest Addiction Technology Transfer Center Asst. Research

ResultsResults 18 of 40 subjects relapsed18 of 40 subjects relapsed

Bilateral prefrontal cortex, Bilateral prefrontal cortex, striatum, posterior parietal striatum, posterior parietal cortex, and anterior insula were cortex, and anterior insula were more active duringmore active during the the prediction task than the prediction task than the response taskresponse task

Page 54: Methamphetamine: What can Brain Imaging Tell Us? Thomas E. Freese, Ph.D Director Pacific Southwest Addiction Technology Transfer Center Asst. Research

Results ContinuedResults Continued 9 areas within these regions 9 areas within these regions

differentiateddifferentiated relapsing and relapsing and nonrelapsing participantsnonrelapsing participants– Areas included prefrontal, parietal, Areas included prefrontal, parietal,

and insular cortexand insular cortex– Nonrelapsing individuals showed Nonrelapsing individuals showed

more activation in these areasmore activation in these areas

Page 55: Methamphetamine: What can Brain Imaging Tell Us? Thomas E. Freese, Ph.D Director Pacific Southwest Addiction Technology Transfer Center Asst. Research

Results ContinuedResults Continued– Right insula, right posterior cingulate, Right insula, right posterior cingulate,

and right middle temporal gyrus and right middle temporal gyrus response best differentiated between response best differentiated between relapsing and nonrelapsing participantsrelapsing and nonrelapsing participants Cross-validation analysis was able to Cross-validation analysis was able to

correctly predict 19 of 22 who did not correctly predict 19 of 22 who did not relapse and 17 of 18 who relapsedrelapse and 17 of 18 who relapsed

– Right middle frontal gyrus, right middle Right middle frontal gyrus, right middle temporal gyrus, and right posterior temporal gyrus, and right posterior cingulate cortex activation best cingulate cortex activation best predicted time to relapsepredicted time to relapse

Page 56: Methamphetamine: What can Brain Imaging Tell Us? Thomas E. Freese, Ph.D Director Pacific Southwest Addiction Technology Transfer Center Asst. Research

Implications of ResultsImplications of Results

• Neural activation differences are part of a Neural activation differences are part of a system involved with the system involved with the processing of processing of decision makingdecision making. Attenuated activation may . Attenuated activation may represent:represent: Defective assessment abilitiesDefective assessment abilities and and

subsequent reliance on habitual behaviorssubsequent reliance on habitual behaviors Diminished Diminished ability to differentiate choices ability to differentiate choices

that lead to good vs. poor outcomesthat lead to good vs. poor outcomes• fMRI may prove to be a useful clinical tool to fMRI may prove to be a useful clinical tool to

assess relapse susceptibilityassess relapse susceptibility

Page 57: Methamphetamine: What can Brain Imaging Tell Us? Thomas E. Freese, Ph.D Director Pacific Southwest Addiction Technology Transfer Center Asst. Research

Methamphetamine Abuse, HIV Methamphetamine Abuse, HIV Infection Causes Changes in Brain Infection Causes Changes in Brain StructureStructureJernigan,T, et al American Jnl of Psychiatry Aug Jernigan,T, et al American Jnl of Psychiatry Aug 20052005 Methamphetamine abuse and HIV infection Methamphetamine abuse and HIV infection

cause significant cause significant alterations in the size of alterations in the size of certain brain structurescertain brain structures, and in both cases the , and in both cases the changes may be associated with impaired changes may be associated with impaired cognitive functions, such as cognitive functions, such as difficulties in difficulties in learning new informationlearning new information, , solving problemssolving problems, , maintaining attention maintaining attention and quickly and quickly processing processing informationinformation..

Co-occurring methamphetamine abuse and Co-occurring methamphetamine abuse and HIV infection appears to result in HIV infection appears to result in greater greater impairment impairment than each condition alone than each condition alone

Page 58: Methamphetamine: What can Brain Imaging Tell Us? Thomas E. Freese, Ph.D Director Pacific Southwest Addiction Technology Transfer Center Asst. Research

Methamphetamine Abuse, HIV Methamphetamine Abuse, HIV Infection Causes Changes in Brain Infection Causes Changes in Brain StructureStructureJernigan,T, et al American Jnl of Psychiatry Aug Jernigan,T, et al American Jnl of Psychiatry Aug 20052005

Brain scans to analyze structural volume changes in Brain scans to analyze structural volume changes in 103 adults divided among four populations103 adults divided among four populations: : methamphetamine abusers who were HIV-positive; methamphetamine abusers who were HIV-positive; methamphetamine abusers who were HIV-negative; methamphetamine abusers who were HIV-negative; nonabusers who were HIV-positive; and nonabusers nonabusers who were HIV-positive; and nonabusers who were HIV-negative. who were HIV-negative.

They also assessedThey also assessed the the ability to think and reasonability to think and reason using a detailed battery of tests that examined using a detailed battery of tests that examined speed of information processing, attention/working speed of information processing, attention/working memory, learning and delayed recall, memory, learning and delayed recall, abstraction/executive functioning, verbal fluency, abstraction/executive functioning, verbal fluency, and motor functioning.and motor functioning.

Page 59: Methamphetamine: What can Brain Imaging Tell Us? Thomas E. Freese, Ph.D Director Pacific Southwest Addiction Technology Transfer Center Asst. Research

Methamphetamine Abuse, HIV Methamphetamine Abuse, HIV Infection Causes Changes in Brain Infection Causes Changes in Brain StructureStructureJernigan,T, et al American Jnl of Psychiatry Aug Jernigan,T, et al American Jnl of Psychiatry Aug 20052005

Methamphetamine abuse is associated with changes Methamphetamine abuse is associated with changes in the the brain’s parietal cortex (which helps people in the the brain’s parietal cortex (which helps people to to understand and pay attention to what’s going on understand and pay attention to what’s going on around themaround them) and basal ganglia () and basal ganglia (linked to motor linked to motor function and motivationfunction and motivation). ).

The degree of change in the parietal cortex was The degree of change in the parietal cortex was associated with worse cognitive function associated with worse cognitive function

HIV infection is associated with prominent volume HIV infection is associated with prominent volume losses in the cerebral cortex (losses in the cerebral cortex (involved in higher involved in higher thought, reasoningthought, reasoning, and , and memorymemory), basal ganglia, and ), basal ganglia, and hippocampus (hippocampus (involved in memory and learninginvolved in memory and learning))

Page 60: Methamphetamine: What can Brain Imaging Tell Us? Thomas E. Freese, Ph.D Director Pacific Southwest Addiction Technology Transfer Center Asst. Research

Methamphetamine Abuse, HIV Methamphetamine Abuse, HIV Infection Causes Changes in Brain Infection Causes Changes in Brain StructureStructureJernigan,T, et al American Jnl of Psychiatry Aug Jernigan,T, et al American Jnl of Psychiatry Aug 20052005

““In HIV-infected people, the cognitive impairments In HIV-infected people, the cognitive impairments are associated with are associated with decreased employment and decreased employment and vocational abilitiesvocational abilities, , difficulties with medication difficulties with medication managementmanagement, , impaired driving impaired driving performance, and performance, and problems with general problems with general activities of daily livingactivities of daily living, , such as managing money,” such as managing money,”

““The impact of methamphetamine could The impact of methamphetamine could potentially potentially affect treatment and relapse affect treatment and relapse prevention prevention efforts, as well as things like efforts, as well as things like money money management management and and driving driving performance.”performance.”

Page 61: Methamphetamine: What can Brain Imaging Tell Us? Thomas E. Freese, Ph.D Director Pacific Southwest Addiction Technology Transfer Center Asst. Research

Methamphetamine Abuse, HIV Methamphetamine Abuse, HIV Infection Causes Changes in Brain Infection Causes Changes in Brain StructureStructureJernigan,T, et al American Jnl of Psychiatry Aug Jernigan,T, et al American Jnl of Psychiatry Aug 20052005

YoungerYounger methamphetamine abusers methamphetamine abusers showed showed larger effectslarger effects in some brain regions. in some brain regions.

Among HIV-infected individuals, the Among HIV-infected individuals, the researchers noted a direct researchers noted a direct association association between the severity of the infection and between the severity of the infection and greater loss of brain mattergreater loss of brain matter. .

In methamphetamine abusers who are also In methamphetamine abusers who are also HIV-positive, decreased volumes are HIV-positive, decreased volumes are correlated with correlated with increased cognitive increased cognitive impairment in one brain regionimpairment in one brain region, the , the hippocampus. hippocampus.

Page 62: Methamphetamine: What can Brain Imaging Tell Us? Thomas E. Freese, Ph.D Director Pacific Southwest Addiction Technology Transfer Center Asst. Research
Page 63: Methamphetamine: What can Brain Imaging Tell Us? Thomas E. Freese, Ph.D Director Pacific Southwest Addiction Technology Transfer Center Asst. Research
Page 64: Methamphetamine: What can Brain Imaging Tell Us? Thomas E. Freese, Ph.D Director Pacific Southwest Addiction Technology Transfer Center Asst. Research
Page 65: Methamphetamine: What can Brain Imaging Tell Us? Thomas E. Freese, Ph.D Director Pacific Southwest Addiction Technology Transfer Center Asst. Research
Page 66: Methamphetamine: What can Brain Imaging Tell Us? Thomas E. Freese, Ph.D Director Pacific Southwest Addiction Technology Transfer Center Asst. Research

For more information, contact:For more information, contact:

Thomas E. Freese, Ph.DThomas E. Freese, Ph.D..310-445-0874 x304310-445-0874 x304

[email protected]@ix.netcom.com